By Cameron Schmitt
The swine industry enters 2027 with a familiar but intensifying challenge: protecting herd health in a production environment shaped by global disease movement, labor constraints, market pressure and rising expectations for transparency. For producers and veterinarians, the year ahead will not be defined by a single pathogen. Instead, success will depend on how well farms integrate surveillance, biosecurity, diagnostics, vaccination, transport discipline and data-based decision-making into daily operations.
Assess the Threats
Endemic disease remains the most immediate economic concern. Porcine reproductive and respiratory syndrome (PRRS) virus will continue to command attention because of its impact on sow performance, nursery health, finishing mortality and systemwide productivity.
The 2027 outlook suggests that PRRS control will increasingly move from reactive outbreak response to coordinated regional and production-system strategies. Better sequencing, improved sharing of diagnostic trends and renewed discussion around elimination will help producers identify whether vaccination, closure, exposure, filtration, flow changes or targeted biosecurity investments offer the best return.
Enteric disease pressure also deserves close attention. Porcine epidemic diarrhea virus, porcine delta-coronavirus and other enteric pathogens can regain momentum when sanitation, trailer washing, pig flow or downtime practices slip.
In 2027, the most resilient systems will be those that treat transport biosecurity as a core health tool rather than a seasonal checklist. Clean-dirty line discipline, verified drying, load-out procedures and communication between farms, truckers, markets and packers will remain essential to reducing pathogen spread.
Prepare Before the Crisis
Foreign animal disease preparedness is likely to be the dominant strategic issue. African swine fever and classical swine fever are not present in the U.S. commercial herd, but their global persistence keeps the risk real.
The implications of an introduction would reach far beyond animal health, disrupting animal movement, export markets, packing capacity and rural economies. Programs that strengthen traceability, premises identification, movement records, surveillance and disease-status certification will become increasingly important. Participation in preparedness initiatives such as the U.S. Swine Health Improvement Plan can help farms demonstrate readiness while building confidence among trade partners and animal health officials.
Emerging and re-emerging risks will require broader thinking. Influenza A virus in swine will remain a concern because of its capacity for reassortment and its relevance to both animal and public health. Feral swine, wildlife interfaces and outdoor-access production will require special attention, particularly where contact with other animals, contaminated equipment or human traffic can introduce new risks.
Pseudorabies and New World screwworm underscore the need for producers to monitor developments outside their own region, because global disease events can quickly influence domestic preparedness priorities.
Tech as a Key Tool
Technology will play a larger role in swine health management in 2027, but it will not replace sound veterinary judgment. Near real-time disease monitoring, diagnostic dashboards, production-data integration and artificial intelligence tools can help identify unusual patterns earlier. However, data are only valuable when they trigger practical action. The strongest operations will pair digital surveillance with trained caretakers who know normal pig behavior, recognize early clinical signs and communicate concerns quickly.
Antimicrobial stewardship will remain central to herd-health planning. Pressure to use antibiotics responsibly will continue, but stewardship should not be viewed as a constraint on animal care. Rather, it should encourage stronger prevention: better ventilation, water quality, stocking density, vaccination protocols, gilt acclimation and timely diagnostics. When pigs are healthier at the population level, the need for treatment declines, and producer confidence in therapeutic decisions improves.
The 2027 swine health outlook is therefore one of cautious urgency. The tools available to the industry are better than they were a decade ago, but disease pressure is also more complex. Producers who invest in preparedness before a crisis, use diagnostics to guide decisions, strengthen transport and site biosecurity and collaborate regionally will be best positioned to protect animal health and welfare and business continuity.
In the coming year, swine health will be less about isolated interventions and more about connected systems — people, pigs, data and protocols working together to reduce risk.
Cameron Schmitt, DVM, is executive vice president of Pipestone Veterinary Services and vice president of the Pipestone Holdings board.
